Previously untreated patients were randomly assigned in a @:@ ratio to receive either @ weeks or @ weeks of daclatasvir at a standard dose of @ mg daily ( with dose adjustment for concomitant antiretroviral medications ) plus @ mg of sofosbuvir daily .